REG - MyHealthChecked PLC - At-home wellness tests to launch on Amazon

MyhealthcheckedAnnouncement

26/07/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220726:nRSZ6462Ta&default-theme=true

RNS Number : 6462T  MyHealthChecked PLC  26 July 2022

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

 

At-home wellness tests to launch on Amazon

 

MyHealthChecked Plc (AIM: MHC), the consumer home-testing healthcare company,
announces that its suite of cheek- swab DNA at-home wellness tests will be
available from today to purchase through the UK site of online retailer,
Amazon.com, Inc. (NASDAQ: AMZN) ("Amazon").

 

The tests were initially launched by MyHealthChecked and available for
purchase on the Company's website on 14 June 2022
(https://www.londonstockexchange.com/news-article/MHC/launch-of-at-home-wellness-tests/15493390)
. Customers will now be able to purchase four tests directly via Amazon UK,
with the launch of the Glucose Management DNA test expected to follow. The
tests will be priced at £54 per test, and will be delivered to users by Royal
Mail Tracked 24.

 

The tests that will be available in MyHealthChecked's at-home wellness range
and launching on Amazon are:

 

 Intolerances & Sensitivities      to identify genetic variants associated with intolerances, such as gluten and
                                   lactose, as well as sensitivities, including caffeine, salt and alcohol
 Weight Management                 intended for use by those wishing to identify their genetic susceptibility to
                                   becoming overweight and their responsiveness to weight loss interventions at a
                                   molecular and metabolic level, including genetic interactions
 Heart Profile                     identifying how individuals respond differently to diet. This will facilitate
                                   optimisation of heart health parameters by using personalised dietary advice
 Vitamins & Minerals               this test indicates the predisposition towards a nutrient deficiency or
                                   toxicity, to highlight nutrients or supplements an individual should increase
                                   or deprioritise

 

MyHealthChecked's range of at-home wellness tests allow individuals to make
more informed choices about their health and well-being from personalised,
accurate results and advice. Understanding genetic disposition provides
individuals with the power to be proactive about their health and well-being
through lifestyle and diet management, allowing individuals to fully unlock
their health potential.

 

The launch of the tests via Amazon supports the Company's strategy of
accessible healthcare for all, enabling the Company to broaden its reach, as
the demand for health and wellness tests expands. All tests will continue to
be available via the MyHealthChecked website (www.myhealthchecked.com/wellness
(http://www.myhealthchecked.com/wellness) ), also priced at £54 per test,
which also provides access to information about the benefits of DNA use,
details of the Scientific Advisory team and full customer facts and questions.

 

Penny McCormick, Chief Executive Officer of MyHealthChecked Plc, said: "We
are excited to be launching our wellness tests with Amazon and believe this
will greatly increase the accessibility of our product range. Following the
success of our partnership with the UK's top high street pharmacy retailers
for our COVID testing service, we have seen the real value that additional
retail partners can bring to the business by broadening our customer base and
significantly increasing our market share."

 

For further information contact:

 

 MyHealthChecked plc                                                www.myhealthchecked.com (http://www.myhealthchecked.com)
 Penny McCormick, Chief Executive Officer                           via Walbrook PR

 SPARK Advisory Partners Limited (NOMAD)                            Tel: +44 (0)20 3368 3550
 Neil Baldwin

 Oberon Capital Ltd (Broker)                                        Tel: +44 (0)20 3179 5344
 Mike Seabrook                                                      mikeseabrook@oberoninvestments.com (mailto:mikeseabrook@oberoninvestments.com)

 Walbrook PR Ltd (Media & IR)      Tel: +44 (0)20 7933 8780 or myhealthcheckedplc@walbrookpr.com
                                   (mailto:myhealthcheckedplc@walbrookpr.com)
 Paul McManus / Alice Woodings                                      Mob: +44(0)7980 541 893 / +44(0) 7407 804 654

 

 

About MyHealthChecked PLC (www.myhealthcheckedplc.com
(http://www.myhealthcheckedplc.com) )

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK
healthcare company focused on a range of at-home healthcare and wellness
tests.

 

MyHealthChecked is the umbrella brand of a range of at-home DNA and RNA tests
that have been developed following the acquisition of The Genome Store in
November 2020. The tests are available online, and in some cases, for
over-the-counter purchase.

 

The MyHealthChecked portfolio has been identified as part of a change in
mindset as customers become more familiar with the concept of accessible
healthcare in the growing at home testing kit market with a focus on
accessibility at the right price, led by UK-based experts.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUVRURUWUBUAR